Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Endo International plc is a drug manufacturers-specialty & generic business based in the US. Endo International shares (ENDP) are listed on the NASDAQ and all prices are listed in US Dollars. Endo International employs 3,397 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $3.21 |
|---|---|
| 52-week range | $1.94 - $10.89 |
| 50-day moving average | $4.91 |
| 200-day moving average | $4.63 |
| Wall St. target price | $6.40 |
| PE ratio | 11.1986 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.29 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.21 from 2022-01-21
| 1 week (2022-01-14) | -1.83% |
|---|---|
| 1 month (2021-12-23) | -24.47% |
| 3 months (2021-10-22) | -29.61% |
| 6 months (2021-07-23) | -35.80% |
| 1 year (2021-01-22) | -53.68% |
|---|---|
| 2 years (2020-01-24) | -45.78% |
| 3 years (2019-01-24) | 9.52 |
| 5 years (2017-01-24) | 11.85 |
Valuing Endo International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Endo International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Endo International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, Endo International shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Endo International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $560.1 million.
The EBITDA is a measure of a Endo International's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $3 billion |
|---|---|
| Operating margin TTM | 26.55% |
| Gross profit TTM | $1.5 billion |
| Return on assets TTM | 5.34% |
| Return on equity TTM | 0% |
| Profit margin | 2.3% |
| Book value | $-2.61 |
| Market capitalisation | $764.1 million |
TTM: trailing 12 months
We're not expecting Endo International to pay a dividend over the next 12 months.
Over the last 12 months, Endo International's shares have ranged in value from as little as $1.94 up to $10.89. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Endo International's is 1.0973. This would suggest that Endo International's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.